Chairman Clyburn’s Opening Statement: Ensuring Scientific Integrity at Our Nation’s Public Health Agencies

Summary

This press releases page of the Select Subcommittee on the Coronavirus Crisis lists releases dated March 29 to April 29, 2022, under Chairman Rep. James E. Clyburn. An April 27, 2022 release describes a staff report on the Trump Administration's approval of a $700 million CARES Act national security loan to trucking company YRC Worldwide Inc., stating it represented 95% of the funds disbursed under that program. An April 14, 2022 release reports a letter from Rep. Carolyn B. Maloney and Clyburn to ID.me CEO Blake Hall on facial recognition contracts. Other releases cover an April 29 hearing on scientific integrity and a GAO report on a $265 million coronavirus public relations campaign.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

Press Releases

Chairman Clyburn’s Opening Statement at Hearing on “Ensuring Scientific Integrity at Our Nation’s Public Health Agencies”

April 29, 2022

Press Release

Washington, D.C. (April 29, 2022) – Below is Select Subcommittee on the Coronavirus Crisis Chairman James E. Clyburn’s opening statement, as delivered, for today’s hearing with Government Accountability Office officials and experts on “Ensuring Scientific Integrity at Our Nation’s Public Health Agencies.”

Select Subcommittee Releases New Findings Detailing Trump Administration’s Political Interference in Early Pandemic Response

April 29, 2022

Press Release

Washington, D.C. (April 29, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released new evidence from the Select Subcommittee’s ongoing investigation into the Trump Administration’s political interference in the nation’s coronavirus response in advance of a hearing at 9:00 a.m. ET on ensuring scientific integrity in the nation’s public health agencies. Consistent with a recent report from the Government Accountability Office (GAO)—which found that government scientists observed incidents of political interference in scientific decision-making but did not report them for fear of retaliation or because they believed superiors already knew—today’s evidence sheds new light on the extent to which Trump Administration officials overruled, undermined, and muzzled career public health experts during the critical first year of the pandemic.

Select Subcommittee Staff Report Shows Trump Political Appointees Overruled Career DOD Officials to Approve $700 Million National Security Loan That Violated CARES Act Terms

April 27, 2022

Press Release

Washington, D.C. (April 27, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, released a staff report that lays out troubling new evidence regarding the Trump Administration’s approval of a $700 million loan under the Coronavirus Aid, Relief and Economic Security (CARES) Act program for companies “critical to maintaining national security.” This loan to trucking company YRC Worldwide Inc. (now named Yellow Corporation) represented 95% of the total funds disbursed under the CARES Act national security loan program.

Clyburn Requests FDA Briefing on Status of Coronavirus Vaccines for Young Children

April 25, 2022

Press Release

Washington, D.C. (April 25, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to Food and Drug Administration (FDA) Commissioner Dr. Robert M. Califf requesting a staff briefing on the status of coronavirus vaccine candidates for young children.

Government Watchdog to Testify on New Report Supporting Select Subcommittee Findings of Trump Administration Political Interference in Pandemic Response

April 20, 2022

Press Release

Washington, D.C. (April 20, 2022) – On Friday, April 29, 2022, at 9:00 a.m. ET, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid hearing with the United States Comptroller General and other experts on ensuring scientific integrity at federal public health agencies. The hearing will examine a new report released today from the Government Accountability Office (GAO) finding that career scientists observed incidents of political interference that resulted in the alteration or suppression of scientific findings related to the coronavirus.

Maloney and Clyburn Launch Investigation into Use of ID.me Facial Recognition Technology in Public Services

April 14, 2022

Press Release

Washington, D.C. (April 14, 2022)—Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to ID.me CEO Blake Hall, requesting documents and information related to the company’s contracts with federal, state, and local governments for use of its facial recognition technology. The Chairs raised concerns with widespread issues related to ID.me’s services, including how ID.me’s technology may have undermined the effectiveness, efficiency, and equity of unemployment assistance programs during the coronavirus pandemic.

Select Subcommittee Seeks Interviews with Senior Trump Administration Officials on Pandemic Response Failures

April 11, 2022

Press Release

Washington, D.C. (April 11, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent letters to two Trump Administration officials who held senior positions at the Department of Health and Human Services (HHS)—former Assistant Secretary for Health Dr. Brett Giroir and former Assistant Secretary for Preparedness and Response (ASPR) Dr. Robert Kadlec—seeking documents and transcribed interviews regarding their roles in the federal government’s pandemic response.

Chairman Clyburn’s Opening Statement at Hearing on “Moving Beyond the Coronavirus Crisis: The Biden Administration’s Progress in Combating the Pandemic and Plan for the Next Phase”

March 30, 2022

Press Release

Washington, D.C. (March 30, 2022) – Below is Select Subcommittee on the Coronavirus Crisis Chairman James E. Clyburn’s opening statement, as delivered, for today’s hearing with senior Biden Administration officials on “Moving Beyond the Coronavirus Crisis: The Biden Administration’s Progress in Combating the Pandemic and Plan for the Next Phase.”

Senior Biden Administration Officials Testify Before Select Subcommittee on New Pandemic Phase

March 30, 2022

Press Release

Washington, D.C. (March 30, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with senior Biden Administration officials to discuss the current phase of the pandemic, the Administration’s National COVID-19 Preparedness Plan, and how Americans would be impacted if Congress fails to provide the funding necessary to sustain and build on the progress made to date.

Clyburn Issues Statement on New Watchdog Report on Misconduct in Trump Administration’s Coronavirus Celebrity Ad Campaign

March 29, 2022

Press Release

Washington, D.C. (March 29, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued a statement on a Government Accountability Office report on the $265 million coronavirus public relations campaign led by the Trump Administration’s Office of the Assistant Secretary for Public Affairs in the Department of Health and Human Services which has been the subject of a Select Subcommittee joint inquiry into Trump Administration political appointees’ plans to use taxpayer dollars to advance a partisan political agenda and direct taxpayer money to their friends and allies.

File and source

File

index-news-press-releases-5.html

Size

35,910 bytes

SHA-256

cd10446d9c0c805b8257f149d8a987a4646db753ad86f1c570d2d269762b7799

Our copy

index-news-press-releases-5.html

Original

No public link identified.